High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants

Journal of Orthopaedic Science

Volumn 10, Issue 6, 2005, Pages 622-626

  Eberhardt, Christian ^a   Schwarz, Markus ^b   Kurth, Andreas H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; IBANDRONIC ACID; SODIUM CHLORIDE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE REGENERATION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEMUR; IMPLANT; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; RAT; STATISTICAL SIGNIFICANCE;

EID: 28244445905     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-005-0955-z     Document Type: Article

References (29)

1. H Weinans R Huiskes HJ Grootenboer 1993 Quantitative analysis of bone reactions to relative motions at implant bone interfaces J Biomechanics 26 1271 81
2. PI Branemark BO Hansson R Adell U Breine J Lindstrom O Hallen 1977 Osseointegrated implants in the treatment of edentulous jaw: experience from a 10 year period Scand J Plast Reconstr Surg Suppl 16 1 132
3. SM Piliar JM Lee C Maiatopolous 1996 Observations of the effect of movement on bone ingrowth into porous-surfaced implants Clin Orthop 208 108 13
4. H Denissen E van Beek T van den Bos J de Blieck C Klein A Van den Hooff 1997 Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro J Bone Miner Res 12 290 7
5. GI Im SA Qureshi J Kenney HE Rubash AS Shanbhag 2004 Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 4105 15
6. AS Shanbhag JA Kenney C Manning 2000 Mitogenic effect of bisphosphonate on osteblastic cells Trans Orthop Res Soc 25 688
7. N Giuliani M Pedrazzoni G Negri G Passeri M Impicciatore G Girasole 1998 Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodule in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo Bone 22 455 61
8. CR Bragdon S Biggs S Wintle 2000 Inhibtion of disuse osteopenia around a canine THR under the influence of alendronate Trans Orthop Res Soc 25 137
9. A Pataki K Müller JR Green YF Ma QN Li WS Jee 1997 Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment Anat Rec 249 458 68
10. SJ Meraw CM Reeve PC Wollan 1999 Use of alendronate in peri-implant defect regeneration J Periodontol 70 151 8
11. T Hennigs M Arabmotlagh A Schwarz L Zichner 2002 Dose-dependent prevention of early periprosthetic bone loss by alendronate Z Orthop 140 42 7
12. TA Soininvaara JS Jurvelin HJ Miettinen OT Suomalainen EM Alhava PJ Kroger 2002 Effect of alendronate on periprosthetic bone loss after knee arthroplasty: a one-year, randomized, controlled trial of 19 patients Calcif Tissue Int 71 472 7
13. C Eberhardt J Sayer E Grüner 2002 Ibandronate reduces the time of implant osseointegration in a rat model Bone 30 Suppl 40
14. YH An 1999 Methods of evaluation in orthopaedic animal research YH An RJ Friedman Animal models in orthopaedic research CRC Press Boca Raton 92 3
15. RJ Friedman YH An J Ming RA Draughn TW Bauer 1996 Influence of biomaterial surface texture on bone ingrowth in the rabbit femur J Orthop Res 14 455 64
16. I Fogelman 1982 Diphosphonate bone scanning agents: current concepts Eur J Nucl Med 7 506 9
17. R Russel M Rogers 1999 Bisphosphonates: from the laboratory to the clinic and back again Bone 25 97 106
18. J Astrand P Aspenberg 2002 Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats Acta Orthop Scand 73 30
19. AS Shanbhag D May C Cha 1999 Enhancing net bone formation in canine total hip components with bisphosphonates Trans Orthop Res Soc 24 255
20. SE Papapoulos 2003 Ibandronate, a potent new bisphosphonate, in the management of postmenopausal osteoporosis Int J Clin Pract 57 417 22
21. RC Schimmer F Bauss 2003 Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies Clin Ther 25 19 34
22. J Body I Mancini 2002 Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer 10 399 407
23. SH Ralston D Thiébaud Z Herrmann EU Steinhauer B Thurlimann MR Lichinitser 1997 Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia Br J Cancer 75 295 300
24. RC Muhlbauer F Bauss R Schenk M Janner E Bosies K Strein 1991 BM 21.0955, a potent new bisphosphonate to inhibit bone resorption J Bone Miner Res 6 1003 11
25. B Scammell 1999 Alendronate prevents periprosthetic bone loss: 2 year results J Bone Miner Res Suppl 14 341
26. JD Bobyn SA Hacking JJ Krygier EJ Harvey DG Little M Tanzer 2005 Zoledronic acid causes enhancement of bone growth into porous implants J Bone Joint Surg Br 87 416 20
27. A Wilke J Orth M Lomb R Fuhrmann H Kienapfel P Griss 1998 Biocompatibility analysis of different biomaterials in human bone marrow cell cultures J Biomed Mater Res 40 301 6
28. Y Okamoto 1995 Accumulation of technetium-99m methylene diphosphonate: conditions affecting adsorption to hydroxyapatite Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 115 9
29. AI Rahmy AJ Tonino WD Tan 1994 Quantitative analysis of technetium-99m-methylene diphosphonate uptake in unilateral hydroxyapatite- coated total hip prostheses: first year of follow-up J Nucl Med 35 1788 91